Comparison Overview

Pii, A Jabil Company

VS

The Janssen Pharmaceutical Companies of Johnson & Johnson

Pii, A Jabil Company

10819 Gilroy Road, Hunt Valley, 21031, US
Last Update: 2025-12-23
Between 650 and 699

Pharmaceutics International Inc. (Pii) is a leading Contract Development and Manufacturing Organization (CDMO) that provides comprehensive solutions for aseptic and oral dosage forms. Founded in 1994 by Dr. Syed Abidi, a pioneering formulation scientist, Pii has over 30 years of experience handling complex formulations, potent compounds, and controlled substances. Based in Hunt Valley, MD, Pii’s capabilities include lyophilization, high potency isolation, and robotic filling. Our expert teams ensure the highest quality and safety standards, supporting small to medium-volume projects with scalable solutions and unmatched flexibility. Committed to client-centric drug development, Pii's mission is to enhance quality of life through innovative and high-quality pharmaceuticals. Discover more about our services and how we can support your projects at www.pharm-int.com.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 354
Subsidiaries: 0
12-month incidents
1
Known data breaches
1
Attack type number
1

The Janssen Pharmaceutical Companies of Johnson & Johnson

1000 U.S. Highway 202, Raritan, New Jersey, US
Last Update: 2025-12-17
Between 750 and 799

At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Arterial Hypertension. Visit us: www.janssen.com Follow us: @JanssenGlobal on Twitter and Instagram Watch our videos on our YouTube channel: http://bit.ly/1LY2xQ5

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 14,253
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/pharmaceutics-international.jpeg
Pii, A Jabil Company
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/janssen-pharmaceutical-companies-of-johnson-and-johnson.jpeg
The Janssen Pharmaceutical Companies of Johnson & Johnson
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Pii, A Jabil Company
100%
Compliance Rate
0/4 Standards Verified
The Janssen Pharmaceutical Companies of Johnson & Johnson
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

Pii, A Jabil Company has 8.7% more incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for The Janssen Pharmaceutical Companies of Johnson & Johnson in 2025.

Incident History — Pii, A Jabil Company (X = Date, Y = Severity)

Pii, A Jabil Company cyber incidents detection timeline including parent company and subsidiaries

Incident History — The Janssen Pharmaceutical Companies of Johnson & Johnson (X = Date, Y = Severity)

The Janssen Pharmaceutical Companies of Johnson & Johnson cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/pharmaceutics-international.jpeg
Pii, A Jabil Company
Incidents

Date Detected: 12/2025
Type:Breach
Blog: Blog
https://images.rankiteo.com/companyimages/janssen-pharmaceutical-companies-of-johnson-and-johnson.jpeg
The Janssen Pharmaceutical Companies of Johnson & Johnson
Incidents

No Incident

FAQ

The Janssen Pharmaceutical Companies of Johnson & Johnson company demonstrates a stronger AI Cybersecurity Score compared to Pii, A Jabil Company company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Pii, A Jabil Company company has historically faced a number of disclosed cyber incidents, whereas The Janssen Pharmaceutical Companies of Johnson & Johnson company has not reported any.

In the current year, Pii, A Jabil Company company has reported more cyber incidents than The Janssen Pharmaceutical Companies of Johnson & Johnson company.

Neither The Janssen Pharmaceutical Companies of Johnson & Johnson company nor Pii, A Jabil Company company has reported experiencing a ransomware attack publicly.

Pii, A Jabil Company company has disclosed at least one data breach, while the other The Janssen Pharmaceutical Companies of Johnson & Johnson company has not reported such incidents publicly.

Neither The Janssen Pharmaceutical Companies of Johnson & Johnson company nor Pii, A Jabil Company company has reported experiencing targeted cyberattacks publicly.

Neither Pii, A Jabil Company company nor The Janssen Pharmaceutical Companies of Johnson & Johnson company has reported experiencing or disclosing vulnerabilities publicly.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds any compliance certifications.

Neither company holds any compliance certifications.

The Janssen Pharmaceutical Companies of Johnson & Johnson company has more subsidiaries worldwide compared to Pii, A Jabil Company company.

The Janssen Pharmaceutical Companies of Johnson & Johnson company employs more people globally than Pii, A Jabil Company company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds SOC 2 Type 1 certification.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds SOC 2 Type 2 certification.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds ISO 27001 certification.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds PCI DSS certification.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds HIPAA certification.

Neither Pii, A Jabil Company nor The Janssen Pharmaceutical Companies of Johnson & Johnson holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Marshmallow is a lightweight library for converting complex objects to and from simple Python datatypes. In versions from 3.0.0rc1 to before 3.26.2 and from 4.0.0 to before 4.1.2, Schema.load(data, many=True) is vulnerable to denial of service attacks. A moderately sized request can consume a disproportionate amount of CPU time. This issue has been patched in version 3.26.2 and 4.1.2.

Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
Description

KEDA is a Kubernetes-based Event Driven Autoscaling component. Prior to versions 2.17.3 and 2.18.3, an Arbitrary File Read vulnerability has been identified in KEDA, potentially affecting any KEDA resource that uses TriggerAuthentication to configure HashiCorp Vault authentication. The vulnerability stems from an incorrect or insufficient path validation when loading the Service Account Token specified in spec.hashiCorpVault.credential.serviceAccount. An attacker with permissions to create or modify a TriggerAuthentication resource can exfiltrate the content of any file from the node's filesystem (where the KEDA pod resides) by directing the file's content to a server under their control, as part of the Vault authentication request. The potential impact includes the exfiltration of sensitive system information, such as secrets, keys, or the content of files like /etc/passwd. This issue has been patched in versions 2.17.3 and 2.18.3.

Risk Information
cvss4
Base: 8.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Fedify is a TypeScript library for building federated server apps powered by ActivityPub. Prior to versions 1.6.13, 1.7.14, 1.8.15, and 1.9.2, a Regular Expression Denial of Service (ReDoS) vulnerability exists in Fedify's document loader. The HTML parsing regex at packages/fedify/src/runtime/docloader.ts:259 contains nested quantifiers that cause catastrophic backtracking when processing maliciously crafted HTML responses. This issue has been patched in versions 1.6.13, 1.7.14, 1.8.15, and 1.9.2.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Authenticated Remote Code Execution (RCE) in PluXml CMS 5.8.22 allows an attacker with administrator panel access to inject a malicious PHP webshell into a theme file (e.g., home.php).

Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:N
Description

An issue was discovered in Xiongmai XM530 IP cameras on firmware V5.00.R02.000807D8.10010.346624.S.ONVIF 21.06. The GetStreamUri exposes RTSP URIs containing hardcoded credentials enabling direct unauthorized video stream access.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N